Novavax (NVAX)

Novavax (NVAX) Financial Statements


Novavax Financial Overview

Novavax's market cap is currently ―. The company's EPS TTM is $-3.179; its P/E ratio is -4.94; Novavax is scheduled to report earnings on August 6, 2024, and the estimated EPS forecast is $0.98. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 291.34M$ 186.99M$ 424.43M$ 80.95M$ 357.40M
Gross Profit$ -52.43M$ 186.99M$ 424.43M$ 46.87M$ 175.63M
EBIT-$ -126.42M$ 63.18M$ -291.61M$ -179.91M
EBITDA-$ -115.10M$ 73.25M$ -282.57M$ -172.69M
Net Income Common Stockholders$ -178.39M$ -130.78M$ 58.01M$ -293.90M$ -182.25M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 568.50M$ 651.10M$ 516.27M$ 635.28M$ 1.35B
Total Assets$ 1.80B$ 1.66B$ 1.69B$ 1.54B$ 2.26B
Total Debt$ 229.08M$ 222.11M$ 198.94M$ 199.06M$ 549.78M
Net Debt$ -339.42M$ -428.99M$ -317.33M$ -436.23M$ -797.40M
Total Liabilities$ 2.51B$ 2.34B$ 2.44B$ 2.44B$ 2.89B
Stockholders Equity$ -716.93M$ -678.35M$ -754.52M$ -895.58M$ -634.08M
Cash Flow-
Free Cash Flow-$ -57.86M$ -178.89M$ -345.39M$ -140.80M
Operating Cash Flow$ -176.80M$ -39.70M$ -171.92M$ -325.59M$ -117.78M
Investing Cash Flow$ -9.08M$ -18.39M$ -7.78M$ -23.56M$ -22.06M
Financing Cash Flow$ 100.39M$ 197.12M$ 61.34M$ -354.38M$ 191.44M
Currency in USD

Novavax Earnings and Revenue History

Novavax Debt to Assets

Novavax Cash Flow

Novavax Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis